Synopsis

States like Maine and Oregon are confronting a powerful adversary: the pharmaceutical industry, as they strive to curb ever-rising drug costs. This struggle, detailed in "The Other Drug War," illuminates the complex interplay between scientific advancement and the public's demand for affordable healthcare. The program delves into the efforts of these states to control escalating expenses, facing fierce resistance from powerful corporate interests. It also examines the inherent tension between th